Poongjeon Pharmacy CO.,LTD.

₩2,135As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:298060Healthcare
Country South Korea
PE (Fwd) •••
TSR 6Y CAGR (45.41%)
Div yield —
ROE (41.87%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.43
PE TTM —
TSR TTM (64.06%)
Mkt cap ₩18.87B
ROIC (22.35%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,114
(0.96%)
120.14%
Hold 1|10|5|10|1
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
36.51
37.83
41.19
42.89
12.36%
7.41%
13.59%
24.34%
Revenue₩B
0.985
0.981
0.966
1.015
2.74%
3.47%
1.49%
3.88%
Peers (US$13.92M)
Cap (US$)
PE
23.50M
—
14.83M
—
8.788M
—
Capital
TTM
5Y
10Y
Leveragex
8.346
0.223
0.189
EBIT/Intx
0.368
0.084
0.082
Own earn%
10.95
37.77
36.61
Sh yield%
47.79
36.92
36.10
Owners
Insiders/Inst%
10.58
80.20
Short interest%
2.89
SBC / revenue%
0.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
2–7
$1 testx
—
Incr. ROIC%
2